Navigation Links
Clinical Site Services' Chris Trizna Contributing Author in Diana Anderson-Foster's Newest Release 'Global Issues in Patient Recruitment and Retention'
Date:7/17/2012

GLEN BURNIE, Md., July 17, 2012 /PRNewswire/ -- Chris Trizna, President of Clinical Site Services (CSS), a Maryland company focused on optimizing and accelerating the trial enrollment process for sponsor companies, CROs and investigative sites, is included as a contributing author in Diana Anderson-Foster's newest book, "Global Issues in Patient Recruitment and Retention," published in June 2012 by CenterWatch.

It is well-documented that slow patient enrollment is a global contributor of study delays. Likewise, retaining patients once enrolled can be equally arduous, but just as critical to the completion and success of a clinical trial. In her second book on the subject, industry expert Diana Anderson-Foster tackles for the first time the global challenges posed by these everyday issues and provides thoughtful analysis and strategic solutions to minimize recruitment costs and develop successful global patient recruitment programs. With insight and contributions from thought-leaders in the industry, this guide also delves into the sponsor's perspective on patient recruitment and tackles new emerging topics including technology challenges, phase I recruiting and the role of social media.

"It was a honor to be able to contribute to this book," shared Trizna. "As individuals in the pharmaceutical industry are finding out, global planning for recruitment and retention is a very complex process. Diana's book provides a thorough breakdown of how to approach and find success where global trials are involved."

"Working with global clinical trials requires more than simply providing translation services for each country's recruitment materials," added Trizna. "There is a complex strategy to everything, and it begins with careful planning, research and budgeting."

For more information about "Global Issues in Patient Recruitment and Retention," please visit https://store.centerwatch.com/p-311-global-issues-in-patient-recruitment-and-retention.aspx.

For quantity book orders, please direct the inquiries to sales@centerwatch.com.

About Clinical Site Services

Clinical Site Services (CSS) is a site performance company that provides solutions to increase the enrollment potential for investigative sites. Through a proprietary, integrated process, CSS strives to reduce the costs and timelines associated with recruitment subjects for clinical studies.

For More Information

Visit www.ClinicalSiteServices.com, or contact Jennifer Whitlock, Vice President, at jwhitlock@clinicalsiteservices.com or 443-308-5803.

Contact:

Jennifer Whitlock
Clinical Site Services
P: 443-308-5803
F: 410-553-0087
jwhitlock@clinicalsiteservices.com
www.clinicalsiteservices.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Clinical Site Services
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. ERT Granted Patents on Clinical Trial Participant Compliance
2. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
3. Healthcare Cloud Computing (Clinical, EMR, SaaS, Private, Public, Hybrid) Market - Global Trends, Challenges, Opportunities & Forecasts (2012 - 2017)
4. Beyond Batten Disease Foundation and American Brain Foundation Launch First Clinical Research Fellowship to Treat and Cure Juvenile Batten Disease
5. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
6. Access Pharmaceuticals to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. Agility Clinical, Inc., a Specialty Contract Research Organization is Formed
9. Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
10. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
11. OrbusNeichs Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... published their findings on what they believe could be a new and helpful ... the new research. Click here to read it now. , Biomarkers ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a range ... place between the two entities said Poloz. Speaking ... Ottawa , he pointed to the country,s inflation ... federal government. "In ... "Both institutions have common economic goals, why not sit down ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):